Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Capasso

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.
The Journal of Molecular Diagnostics : JMD|October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology StudyAlexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Minimally invasive hepatectomy <i>vs.</i> thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonFelice Giuliante, Simone Famularo, Sara Grasselli, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.
The Journal of Molecular Diagnostics : JMD|October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology StudyAlexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Minimally invasive hepatectomy <i>vs.</i> thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonFelice Giuliante, Simone Famularo, Sara Grasselli, et al.
Pageof 17